Preferred Treatment in Pediatric Alopecia Areata
With a paucity of pediatric treatment evidence, researchers sought to evaluate current treatment for pediatric alopecia areata.
Alopecia Areata
FDA Approves First Pill to Treat Severe Alopecia Areata
The first pill to treat adults with severe alopecia areata was approved by the U.S. Food and Drug Administration on Monday.
Significant Hair Regrowth Observed With Investigational JAK Inhibitor in Alopecia Areata Trial
The THRIVE-AA1 trial included adults aged 18 to 65 years with moderate to severe alopecia areata who had at least 50% scalp hair loss.
Pediatric Alopecia Areata Prevalence Increasing
The prevalence and incidence of pediatric alopecia areata across various factors is investigated.
Patient-Reported Outcomes and Clinician Assessments of Alopecia Areata
Researchers sought to examine Alopecia Areata Symptom Impact Scale (AASIS) scores and clinician-assessed Severity of Alopecia Tool (SALT) scores and evaluate possible correlations.
Association Between Alopecia Areata and COVID-19
Literature on clinical studies and reports investigating the association between new-onset alopecia areata or the exacerbation of preexisting alopecia areata following infection with SARS-CoV-2 are reviewed.
Ritlecitinib Treatment for Alopecia Areata Shows Early Response Rates
The efficacy of ritlecitinib in treating patients with alopecia areata is assessed.
Hidradenitis Suppurativa Associated With Higher Risk for Inflammatory Bowel Disease
The incidence of overall IBD, ulcerative colitis, and Crohn’s disease in patients with and without chronic inflammatory skin disease is compared.
Baricitinib Achieves Hair Regrowth in Alopecia Areata
Response differences among subgroups of patients with varying degrees of alopecia severity treated with baricitinib are assessed.
Atopic Diseases Common in Black Patients With Alopecia Areata
A study examines the epidemiology of alopecia areata in a population of exclusively Black patients.
- Loading...
Loading...
Next post in General Dermatology
Loading... 
Loading...